Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 16.04%4.53B | 0.14%2.75B | -0.05%1.29B | -30.45%5.08B | -32.61%3.91B | -18.88%2.74B | -35.95%1.29B | -16.70%7.3B | -9.60%5.8B | -31.72%3.38B |
| Refunds of taxes and levies | -28.24%50.38M | -24.74%40.34M | -0.54%10.76M | 4.30%90.29M | 20.11%70.21M | 34.93%53.59M | -29.60%10.81M | -19.62%86.57M | -50.18%58.46M | -46.72%39.72M |
| Cash received relating to other operating activities | -34.39%75.14M | -42.97%61.88M | -4.36%51.86M | -26.76%185.51M | -38.30%114.52M | 20.53%108.5M | 16.76%54.22M | 159.78%253.27M | 118.90%185.62M | 137.26%90.02M |
| Cash inflows from operating activities | 13.87%4.66B | -1.93%2.85B | -0.23%1.35B | -29.93%5.35B | -32.27%4.09B | -17.26%2.9B | -34.72%1.36B | -14.81%7.64B | -8.67%6.04B | -30.67%3.51B |
| Goods services cash paid | 26.82%4.36B | 18.30%2.73B | 35.97%1.3B | -26.66%4.51B | -29.99%3.44B | -15.30%2.31B | -41.76%952.54M | -25.60%6.15B | -16.34%4.91B | -37.79%2.73B |
| Staff behalf paid | 19.33%289.27M | 19.54%195.97M | 18.39%109.71M | 12.13%328.38M | 8.95%242.4M | 3.35%163.93M | -10.56%92.66M | -0.85%292.85M | -2.18%222.49M | 1.83%158.62M |
| All taxes paid | -7.12%175.1M | -26.13%114.54M | -24.89%54.43M | -40.75%231.29M | -36.29%188.53M | -22.52%155.06M | -32.05%72.47M | -13.41%390.37M | -23.74%295.93M | -27.84%200.13M |
| Cash paid relating to other operating activities | 22.87%191.21M | 16.93%119.59M | -20.53%50.6M | -25.34%197.33M | 7.90%155.62M | 6.57%102.28M | 125.84%63.68M | -18.54%264.31M | -26.01%144.22M | -35.17%95.97M |
| Cash outflows from operating activities | 24.62%5.02B | 15.80%3.16B | 27.82%1.51B | -25.78%5.27B | -27.79%4.03B | -14.17%2.73B | -36.96%1.18B | -23.98%7.1B | -16.57%5.57B | -35.92%3.18B |
| Net cash flows from operating activities | -634.88%-356.99M | -285.14%-316.78M | -189.74%-156.87M | -83.91%87.81M | -85.71%66.74M | -47.49%171.1M | -14.06%174.81M | 249.73%545.7M | 804.45%467.2M | 245.77%325.85M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --60M | --60M | --60M |
| Cash received from returns on investments | -32.94%3.06M | -27.81%2.26M | -54.11%931.81K | -52.03%6.37M | -60.56%4.57M | 26.74%3.13M | 300.88%2.03M | 177.08%13.28M | 211.47%11.58M | -3.83%2.47M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -83.13%1.19M | -83.91%1.13M | -89.70%723.63K | -26.95%7.4M | -0.13%7.07M | 103.21%7.02M | 424.72%7.02M | 538.92%10.13M | 388.68%7.07M | 215.21%3.46M |
| Cash received relating to other investing activities | -3.54%1.85B | 13.72%1.48B | 8.99%766.71M | 28.03%2.54B | 21.00%1.92B | 35.26%1.3B | 239.36%703.5M | -56.22%1.98B | -55.63%1.59B | -61.27%961.73M |
| Cash inflows from investing activities | -3.90%1.85B | 13.10%1.48B | 7.83%768.37M | 23.52%2.55B | 15.98%1.93B | 27.57%1.31B | 240.70%712.56M | -54.44%2.06B | -53.49%1.66B | -58.68%1.03B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -23.12%177.05M | -29.18%100.57M | -13.42%33.11M | 51.07%287.93M | 34.31%230.29M | 122.27%142M | 7.90%38.25M | -29.55%190.6M | -1.65%171.46M | -52.63%63.89M |
| Cash paid to acquire investments | ---- | ---- | ---- | 120.67%33.1M | ---- | ---- | ---- | --15M | ---- | ---- |
| Net cash paid to acquire subsidiaries and other business units | -71.96%9M | -71.96%9M | ---- | ---- | --32.1M | --32.1M | --18.2M | 739.38%42.81M | ---- | ---- |
| Cash paid relating to other investing activities | -6.96%1.88B | 17.52%1.48B | -5.94%790.3M | 29.95%2.57B | 21.60%2.02B | 25.69%1.26B | 179.51%840.2M | -56.76%1.98B | -55.24%1.66B | -59.87%1B |
| Cash outflows from investing activities | -9.51%2.06B | 10.89%1.59B | -8.17%823.41M | 29.87%2.89B | 24.54%2.28B | 34.49%1.43B | 166.82%896.65M | -54.09%2.22B | -52.90%1.83B | -59.50%1.07B |
| Net cash flows from investing activities | 40.28%-210.28M | 12.58%-107.77M | 70.10%-55.05M | -111.96%-338.22M | -109.20%-352.08M | -217.45%-123.27M | -45.07%-184.09M | 49.06%-159.57M | 46.10%-168.3M | 73.44%-38.83M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | 200.00%600K | ---- | ---- | --1.6M | --200K | --200K | --200K | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | 200.00%600K | ---- | ---- | --1.6M | --200K | --200K | --200K | ---- | ---- | ---- |
| Cash from borrowing | 106.80%819.23M | 191.62%594.82M | 1,109.55%167.15M | 9.65%685.48M | -14.23%396.14M | -10.10%203.97M | -70.83%13.82M | -39.09%625.14M | -40.74%461.87M | -52.37%226.88M |
| Cash received relating to other financing activities | 390.00%24.5M | --14M | -25.09%3M | -85.51%14M | 0.00%5M | ---- | --4M | 1,914.01%96.67M | --5M | --5M |
| Cash inflows from financing activities | 110.38%844.33M | 198.19%608.82M | 844.02%170.15M | -2.87%701.09M | -14.04%401.34M | -11.95%204.17M | -61.96%18.02M | -53.34%721.81M | -40.82%466.87M | -52.27%231.88M |
| Borrowing repayment | 35.54%540.42M | 16.94%376.69M | -19.01%69M | -34.79%504.5M | -34.68%398.7M | 11.54%322.11M | 79.75%85.2M | 120.01%773.6M | 109.76%610.4M | 100.55%288.79M |
| Dividend interest payment | 36.20%26.86M | 59.96%18.13M | -23.75%5.57M | -78.83%33.56M | -86.79%19.72M | -91.83%11.34M | -27.73%7.3M | 88.70%158.53M | 96.88%149.32M | 110.82%138.75M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.64M | ---- | ---- |
| Cash payments relating to other financing activities | -41.10%30.48M | -64.78%17.81M | -87.57%3.91M | 49.32%113.22M | -3.73%51.76M | 16.82%50.58M | 7.55%31.49M | 269.22%75.82M | 422.14%53.76M | 1,002.69%43.3M |
| Cash outflows from financing activities | 27.13%597.76M | 7.45%412.64M | -36.70%78.48M | -35.39%651.27M | -42.20%470.18M | -18.44%384.03M | 42.88%123.99M | 120.96%1.01B | 115.70%813.48M | 120.29%470.84M |
| Net cash flows from financing activities | 458.18%246.57M | 209.07%196.18M | 186.51%91.67M | 117.41%49.82M | 80.14%-68.84M | 24.73%-179.86M | -168.98%-105.96M | -126.23%-286.15M | -184.19%-346.61M | -187.82%-238.96M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 153.47%190.52K | -14.29%447.37K | 181.32%238.43K | -25.98%399.19K | -144.72%-356.34K | -45.93%521.96K | -37.15%-293.2K | -40.56%539.27K | -32.05%796.81K | 71.39%965.34K |
| Net increase in cash and cash equivalents | 9.60%-320.51M | -73.32%-227.92M | -3.88%-120.02M | -299.14%-200.19M | -655.71%-354.54M | -368.27%-131.51M | -413.10%-115.54M | -75.71%100.53M | -236.80%-46.91M | -77.79%49.02M |
| Add:Begin period cash and cash equivalents | -23.30%659.06M | -23.30%659.06M | -23.30%659.06M | 13.25%859.25M | 13.25%859.25M | 13.25%859.25M | 13.25%859.25M | 120.04%758.72M | 120.04%758.72M | 120.04%758.72M |
| End period cash equivalent | -32.92%338.55M | -40.76%431.13M | -27.52%539.04M | -23.30%659.06M | -29.09%504.71M | -9.90%727.74M | -6.52%743.71M | 13.25%859.25M | 87.76%711.81M | 42.83%807.74M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.